期刊文献+

大肠癌CD24的表达及其与肿瘤细胞增殖和血管形成的关系 被引量:4

Expression of CD24 and its relationship with angiogenesis and tumor cell proliferation in colorectal carcinoma
下载PDF
导出
摘要 目的:探讨CD24在大肠癌中的表达及其与细胞增殖、血管生成的关系.方法:运用流式细胞术直接免疫荧光法检测66例大肠癌肿瘤组织及相应正常大肠黏膜CD24的表达量.CD24蛋白表达量以阳性率(PPC)和平均荧光强度MFI值表示.运用免疫组织化学法检测肿瘤组织CD34,PCNA的表达情况,根据CD34的染色情况计算出大肠癌组织的微血管密度(microvessel density),根据PCNA染色情况计算出肿瘤细PCNA标记指数.结果:大肠癌肿瘤组织CD24阳性率90.40%(75.10%-96.35%)明显高于相应的癌旁组织36.15%(32.00%-53.28%)(χ2=6.877,P<0.001).大肠癌肿瘤组织CD24蛋白MFI值18.10(11.45-25.43),明显高于正常黏膜组织8.41(5.59-10.33)(χ2=6.934,P<0.001).浸润型、高Dukes分期、高pTNM分期及有淋巴结转移的癌组织中CD24蛋白的平均荧光强度显著高于对应组(P<0.05).浸润型、低分化、高Dukes分期、高pTNM分期及有淋巴结转移的癌组织中CD24蛋白阳性百分率显著高于对应组(P<0.05).在CD24阳性表达病例中,PCNA的表达随着CD24表达强度的升高而升高(P<0.05).大肠腺癌肿瘤细胞CD24阳性表达率与MVD呈正相关(r=0.243,P=0.050).而CD24蛋白平均荧光强度与MVD未见明显相关(r=0.115,P=0.358).结论:CD24在大肠腺癌中表达水平明显上调,并与肿瘤细胞增殖、血管生成密切相关. AIM: To investigate the expression of CD24 and its role in the angiogenesis and tumor cell proliferation in colorectal carcinoma. METHODS: Direct immunofluorescence flow cytometry (FCM) was used to detect the expression of CD24 in 66 specimens of colorectal carcinoma and normal colorectal tissues. The expression of CD24 protein was shown by the percentage of positive cells (PPC) and mean fluorescence index (MFI), The expression of CD34 and proliferating cell nuclear antigen (PCNA) in colorectal carcinoma were detected by immunohistochemistry, Microvessel density (MVD) was figured out according to the positive staining for CD34, The proliferation index of carcinoma cells was figured out according to the expression of PCNA. RESULTS: The values of PPC and MFI were significantly higher in colorectal carcinoma tissue than that in the normal colorectal tissue (PPC: 90.40% vs 36.15%, X2 = 6.877, P 〈 0.001; MFI: 18.10 vs 8.41,χ^2 = 6.934, P 〈 0.001). The values of MFI and PPC were significantly correlated with tumor stages (Dukes and pTNM), lymph noda metastasis and infiltration types (P 〈 0.05). The expression of PCNA was increased with the upregulation of CD24 expression in CD24-positive cases (P 〈 0.05). There was a significant correlation between the positive rate of CD24 expression and the value of MVD in colorectal carcinoma (r = 0.243, P = 0.050). But the value of MFI had no marked correlation with that of MVD in colorectal carcinoma (r = 0.115, P = 0.358). CONCLUSION: CD24 expression is obviously up-regulated in colorectal carcinoma, and it is correlated with the angiogenesis of tumor tissues and proliferation of tumor cells.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第3期260-265,共6页 World Chinese Journal of Digestology
关键词 大肠肿瘤 流式细胞术 GD24 核增殖抗原 微血管密度 Colorectal carcinoma Flow cytometry CD24 Microvessel density Proliferating cell nuclear antigen
  • 相关文献

参考文献21

  • 1Kristiansen G,Pilarsky C,Wissmann C,Kaiser S,Bruemmendorf T,Roepcke S,Dahl E,Hinzmann B,Specht T,Pervan J,Stephan C,Loening S,Dietel M,Rosenthal A.Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.J Pathol 2005, 205:359-376
  • 2Kristiansen G,Pilarsky C,Pervan J,Sturzebecher B,Stephan C,Jung K,Loening S,Rosenthal A,Dietel M.CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.Prostate 2004, 58:183-192
  • 3Kristiansen G,Schluns K,Yongwei Y,Denkert C,Dietel M,Petersen I.CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.Br J Cancer 2003, 88:231-236
  • 4Huang LR,Hsu HC.Cloning and expression of CD24 gene in human hepatocellular carcinoma:a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.Cancer Res 1995, 55:4717-4721
  • 5Su MC,Hsu C,Kao HL,Jeng YM.CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.Cancer Lett 2006, 235:34-39
  • 6Deichmann M,Kurzen H,Egner U,Altevogt P,Hartschuh W.Adhesion molecules CD171(L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas).J Cutan Pathol 2003, 30:363-368
  • 7Poncet C,Frances V,Gristina R,Scheiner C,Pellissier JF,Figarella-Branger D.CD24,a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors.Acta Neuropathol (Berl) 1996, 91:400-408
  • 8Jacob J,Bellach J,Grutzmann R,Alldinger I,Pilarsky C,Dietel M,Kristiansen G.Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.Pancreatology 2004, 4:454-460
  • 9Jung KC,Seo JN,Kim TW,Choi YM,Oh KI,Song HH,Shin HS,Park YE.CD24 Expression in gastric adenocarcinoma is associated with tumor invasiveness.Korean J Pathol 2004, 38:388-393
  • 10Weichert W,Denkert C,Burkhardt M,Gansukh T,Bellach J,Altevogt P,Dietel M,Kristiansen G.Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.Clin Cancer Res 2005, 11:6574-6581

二级参考文献30

  • 1Kay R, Rosten P M, Humphries R K. CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor[J].J Immunol,1991,147(4) :1412-1416.
  • 2Kristiansen G, Denkert C, Schluns K, et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival[ J ]. Am J Pathol,2002,161 (4) : 1215-1221.
  • 3Choi Y L, Kim S H, Shin Y K, et al. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors [ J ]. Gynecol Oncol, 2005,97 (2) :379-386.
  • 4Surowiak P, Matema V, Kaplenko I, et al. Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue [J]. Int J Gynecol Cancer, 2006,16 ( 2 ) : 515 -521.
  • 5Wei J J, Chiriboga L, Mittal K, et al. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata [ J ]. Fertil Steril, 2005,84 (2) :474 -484.
  • 6Nestl A, Von Stein O D, Zatloukal K , et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors [ J ]. Cancer Res ,2001,61 (4) : 1569-1577.
  • 7Kristiansen G, Winzer K J, Mayordomo E, et al. CD24 expression is a new prognostic marker in breast cancer[J].Clin Cancer Res,2003,9( 13 ) :4906-4913.
  • 8Surowiak P, Materna V, Gyorffy B, et al. Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers [ J 1. Br J Cancer, 2006,95 ( 3 ) :339-346.
  • 9Al-Hajj M, Wicha M S, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells[ J]. Proc Natl Acad Sci USA,2003,100( 7 ) :3983-3988.
  • 10Kristiansen G, Schluns K, Yongwei Y, et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients[J]. Br J Cancer,2003,88(2) :231-236.

共引文献12

同被引文献72

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部